GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 26301 - 26350 of 39437 in total
PDB ID UniProt ID Title ▼ Descriptor
7TP4 7TP4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22
7TP4 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22
6XKP P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270
6XKP 6XKP Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270
6XKQ P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250
6XKQ 6XKQ Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250
7JMP P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39
7JMP 7JMP Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39
7JMO P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04
7JMO 7JMO Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04
8SDH P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56
8SDH 8SDH Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56
8SDG 8SDG Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43
8SDG P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43
8SDF P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4
8SDF 8SDF Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4
6XC4 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3
6XC4 6XC4 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3
6XC2 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1
6XC2 6XC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1
7U2E P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688
7U2E 7U2E Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688
7U2D P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20
7U2D 7U2D Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20
7MF1 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1
7MF1 7MF1 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1
8GB5 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9
8GB5 8GB5 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9
8GB6 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6
8GB6 8GB6 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6
8GB7 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7
8GB7 8GB7 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7
7S5R P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16
7S5R 7S5R Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16
6W41 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022
6W41 6W41 Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022
8F0I P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody COVA309-22
8F0I 8F0I Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody COVA309-22
7Y3O P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody BIOLS56
7Y3O 7Y3O Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody BIOLS56
8GF2 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3
8GF2 8GF2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3
7LQ7 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16
7LQ7 7LQ7 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16
7LOP P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022
7LOP 7LOP Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022
6XC7 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022
6XC7 6XC7 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022
6XC3 6XC3 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022
6XC3 P0DTC2 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024